Regulus Therapeutics - PDFSEARCH.IO - Document Search Engine

Regulus Therapeutics
Results: 12

#	Item
1	Analysis from the makers of and Add to Reading List Source URL: www.hydrabiosciences.com Language: English - Date: 2010-11-12 07:31:53 Immunology Medicine Regulus Therapeutics Monoclonal antibodies Antibody Monoclonal antibody therapy Prostate cancer Biology MicroRNA Immune system
2	Breakthrough for treatment of cancer, and other diseases InteRNA Technologies BV is a Utrecht based biotech company that is developing new therapeutics for cancer and other diseases. The approach is based on science deve Add to Reading List Source URL: www.innovatieindezorg.com Language: English - Date: 2014-06-19 03:55:46 MicroRNA Melanoma Drug discovery Rosetta Genomics Santaris Pharma a/s Pharmaceutical sciences Pharmacology Regulus Therapeutics
3	Breast cancer and microRNA Fumiaki Sato, MD, PhD. Associate Professor Department of Breast Surgery, Graduate School of Medicine, Kyoto University. MicroRNA is a species of short[removed]nts) non-coding RNA, which regulate Add to Reading List Source URL: www.ootr-institute.org Language: English - Date: 2013-09-05 22:35:47 Trastuzumab HER2/neu Regulus Therapeutics Mir-17 microRNA precursor family MicroRNA Biology Mir-200
4	January 13, 2014 Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines - New Collaboration Expected to Accelerate and Expand Global Product Value for RNAi Therapeutic Genetic Medi Add to Reading List Source URL: files.shareholder.com Language: English RNA interference Regulus Therapeutics Genzyme RNAI Small interfering RNA Transthyretin Genetics Biology RNA
5	Microsoft Word - Earnings release - final for release.doc Add to Reading List Source URL: www.rosettagenomics.com Language: English - Date: 2013-06-20 11:12:45 Financial ratio Balance sheet Business Regulus Therapeutics Rosetta Genomics MicroRNA Financial statements
6	PRQ3[removed]final for release Add to Reading List Source URL: www.rosettagenomics.com Language: English - Date: 2013-06-20 11:15:49 Rosetta Genomics MicroRNA Regulus Therapeutics
7	FOR IMMEDIATE RELEASE Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes Gaithersburg, MD, October 11, 2012 – Zyngenia, Inc., a biopharmaceutica Add to Reading List Source URL: www.zyngenia.com Language: English - Date: 2013-06-10 17:55:59 Takeda Pharmaceutical Company Pharmaceutical industry Pharmacy Regulus Therapeutics Amgen CancerVax
8	18-19 November 2013, San Diego, USA www.globalengage.co.uk/oligos-peptides.html Oligonucleotide & Peptide Based Therapeutics Congress Global Engage is pleased to announce as part of both their Genomic and Biologic series Add to Reading List Source URL: www.globalengage.co.uk Language: English - Date: 2014-01-10 14:31:57 Aptamer Silence Therapeutics Regulus Therapeutics Small interfering RNA Peptidomimetic RNA interference Immunogenicity Peptide MicroRNA Biology Genetics RNA
9	Monday Feb 10, 2014 Conrad Duke of Windsor Add to Reading List Source URL: www.bio.org Language: English - Date: 2014-03-26 15:05:14 Regulus Therapeutics Gilead Sciences
10	Mirna Therapeutics Announces Scientific Publication that Suggests Enhanced Potency of Lead Therapeutic MicroRNA in Combination with FDA Approved Lung Cancer Drug In vitro data find synergistic drug interaction between mi Add to Reading List Source URL: mirnarx.com Language: English - Date: 2014-02-18 10:40:47 Organic chemistry Biology Erlotinib Targeted therapy Lung cancer Regulus Therapeutics Mir-92 microRNA precursor family MicroRNA Chemistry RNA

UPDATE